Biden Proposes $2.1 Billion in FDA Funding for Pandemic Preparedness and Cancer Moonshot
As the Biden administration attempts to ramp up funding for public health and biomedical science efforts, it has now proposed [...]
DRG Offers COVID-19 Resources on Website
DRG has compiled a suite of resources to support life sciences companies amid the COVID-19 pandemic. "We've assembled resources to [...]
Companies Ramping Up Digital Transformation Plans as Result of COVID-19, Survey Finds
A recent survey by Twilio suggests that a clear majority of companies have sped up their digital transformation plans in [...]
Thompson Spotlights Virtual Research
Syneos Health's David Thompson in a recent Value & Outcomes Spotlight article spotlights how drugmakers are dealing with increased emphasis [...]
Risks vs Rewards of Fast-Tracked Drug Evaluations
A recent article on Pharmacy Times outlines some of the risks and rewards of fast-tracking drug evaluations in the midst [...]
Blog Post Highlights Impact of COVID-19 on Health Care Delivery
A recent Health Populi blog post looks at how the COVID-19 pandemic is shaping health care delivery in the U.S. [...]
Cigna Offering Digital Support for Members with COVID-19
Health insurer Cigna is partnering with Collective Medical and Medocity to offer a new, real-time support tools to help members [...]
PRMA Offers Tips on Working From Home
PRMA Consulting in a recent blog post offers six key tips for bolstering connectivity and productivity while working from home. [...]
JCPH’s Nash Discusses Return to Normalcy After First Wave of COVID-19
Jefferson College of Public Health Founding Dean Emeritus David Nash says testing will be key as the U.S. looks to [...]
How COVID-19 is Impacting Outsourcing Engagements
A recent article on the Future of Sourcing looks at how the outsourcing industry can better navigate the challenges presented [...]
Panel to Highlight Drug Innovation During a Pandemic
A panel discussion during the eyeforpharma Philadelphia 2020 virtual conference is set to discuss ways to incentivize drug innovation during [...]
Opinion: COVID-19 May Prove to be ‘Evidence Fiasco’
The author of a recent opinion piece published on STAT says that while COVID-19 has been branded a once-in-a-century pandemic, [...]
ICER Indefinitely Postpones Public Meetings, Expands Assessment Timelines
In response to the COVID-19 pandemic, the Institute for Clinical and Economic Review (ICER) announced it would indefinitely postpone several [...]
